S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
First Claim
Patent Images
1. A method to identify a therapeutic composition or protocol which ameliorates a disease or undesired condition in a subject, which method relies upon recognition of the existence of, and the interconnections between, eight SAM pathways shown in FIGS. 9, herein, which method comprises:
- (a) determining the presence of said disease or condition in said subject;
(b) identifying any abnormalities in each of said eight SAM pathways and optionaily in the interconnections therebetween by determining(i) concentrations of metabolites, and/or(ii) concentrations or activities of enzymes, and/or(iii) levels of cellular functions,that are participants in, or are results of, SAM pathways thereby obtaining a data set of the differences of said concentrations, activities, and/or levels from corresponding normal concentrations, activities, and/or levels,(c) analyzing said data set by ascertaining, for each difference in concentration, activity, and/or level the position or function of the corresponding metabolite, enzyme or cellular function in said eight SAM pathways or the interconnections therebetween, so as to determine which of one or more metabolites and/or enzymes and/or cellular functions of said SAM pathways is a causative agent of said differences in concentrations, activities or levels in said data set; and
(d) identifying a therapeutic composition or protocol which acts to restore said pathways toward normality, so as to ameliorate said disease or condition,thereby identifying a composition or protocol that ameliorates said disease or condition.
2 Assignments
0 Petitions
Accused Products
Abstract
A new paradigm of disease centers around the metabolic pathways of S-adenosyl-L-methionine (SAM), the intermediates of these pathways and other metabolic pathways influenced by the SAM pathways. Methods are provided to analyze and modulate SAM pathways associated with a disease or condition. Such methods permit identification and utilization of diagnostic and therapeutic protocols and agents for such disease states and conditions.
128 Citations
18 Claims
-
1. A method to identify a therapeutic composition or protocol which ameliorates a disease or undesired condition in a subject, which method relies upon recognition of the existence of, and the interconnections between, eight SAM pathways shown in FIGS. 9, herein, which method comprises:
-
(a) determining the presence of said disease or condition in said subject; (b) identifying any abnormalities in each of said eight SAM pathways and optionaily in the interconnections therebetween by determining (i) concentrations of metabolites, and/or (ii) concentrations or activities of enzymes, and/or (iii) levels of cellular functions, that are participants in, or are results of, SAM pathways thereby obtaining a data set of the differences of said concentrations, activities, and/or levels from corresponding normal concentrations, activities, and/or levels, (c) analyzing said data set by ascertaining, for each difference in concentration, activity, and/or level the position or function of the corresponding metabolite, enzyme or cellular function in said eight SAM pathways or the interconnections therebetween, so as to determine which of one or more metabolites and/or enzymes and/or cellular functions of said SAM pathways is a causative agent of said differences in concentrations, activities or levels in said data set; and (d) identifying a therapeutic composition or protocol which acts to restore said pathways toward normality, so as to ameliorate said disease or condition, thereby identifying a composition or protocol that ameliorates said disease or condition. - View Dependent Claims (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
-
-
2. A method to identify a therapeutic composition or protocol which ameliorates a disease or undesired condition in a subject, which method relies upon recognition of the existence of, and the interconnections between, eight SAM pathways shown in FIGS. 2-9, herein, which method comprises:
-
(a) determining the presence of said disease or condition in said subject, (b) identifying ay abnormalities in each of said eight SAM pathways and in the interconnections therebetween by determining (i) concentrations of metabolites, and/or (ii) concentrations or activities of enzymes, and/or (iii) levels of cellular functions, that are participants in, or are results of, SAM pathways thereby obtaining a data set of the differences from normal concentrations, activities, and/or levels from corresponding normal concentrations, activities, and/or levels; (c) analyzing said data set by ascertaining, for each difference in concentration, activity, and/or level, the position or function of the corresponding metabolite, enzyme or cellular function in said eight SAM pathways or the interconnections therebetween, so as to determine which of one or more metabolites and/or enzymes and/or cellular functions of said SAM pathways is a causative agent of said differences in concentrations, activities or levels in said data set; and (d) identifying a therapeutic composition or protocol which acts to restore said pathways toward normality, so as to ameliorate said disease or condition, wherein said data set is converted into digital computer-readable form.
-
Specification